Treatment Guide: Biologics for Psoriasis

Health & Lifestyle
376

Listen to article (english)

Translate to Spanish or other 102 languages!

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes
As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes

Medical News Today

- Advertisement -

Biologics are injectable medications that pharmaceutical companies make from living cells in a lab or through a biological process. They change or stop specific cytokine activities inside immune cells that cause inflammation in psoriasis. 

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. 

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/biologics-for-psoriasis?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Advance in the Treatment of Acute Heart Failure Identified
Next article
Driscoll Children’s Hospital Prepares for Grand Opening 

More Articles

Larger Families Associated With Reduced Stroke Risk, New UT Health San Antonio Research Shows

Research co-led by UT Health San Antonio, the academic health center of The University of Texas at San Antonio, associates a greater number of live births with a reduced risk of stroke or brain damage for mothers.

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).
- Advertisement -